B&A Oncomedical unveils two innovative therapies for brain tumors
French biotech company B&A Oncomedical announces two major advances in the fight against brain tumors at the 25th annual “Biotech in Europe” Forum in Basel. These new approaches, which target both the tumor and its cerebral microenvironment, aim to slow tumor progression, restore neuronal balance, and prolong patient survival. This represents a real paradigm shift … Read more
